在B+COPD患者中进行三重治疗和临床控制:实用性,前性,随机试验
Alvar Agusti1, José Luis Lopez-Campos2, Marc Miravitlles3
1Cátedra Salud Respiratoria, Universidad Barcelona, Institut Respiratori, Clinic Barcelona, FCRB-IDIBAPS, CIBERES, Spain.
Archivos de bronconeumologia
|May 10, 2024
概括
与双重治疗 (LABA/LAMA/ICS) 相比,三重治疗 (LABA/LAMA/ICS) 可能会改善GOLD B+ COPD患者的临床控制. ANTES B+研究正在评估这一假设,预计结果将在2026年初公布.
科学领域:
- 肺部病理学 肺部病理学
- 临床试验 临床试验
- 药物治疗 药物治疗
背景情况:
- 黄金B型患者往往需要加强治疗.
- 一个特定的亚组 (GOLD B+) 尽管接受了LABA/LAMA治疗,但仍然表现出症状,并经历了恶化.
- 血中乙氨基酸细胞计数 (BEC) 可以识别那些从吸入性皮质类固醇 (ICS) 治疗中受益的患者.
研究的目的:
- 评估三重疗法 (LABA/LAMA/ICS) 是否优于双重疗法 (LABA/LAMA) 在实现和维持GOLD B+ COPD患者的临床控制方面.
- 评估三重治疗对疾病稳定性和症状负担的影响.
主要方法:
- ANTES B+研究是一项前性,随机的实用性试验,涉及1028名GOLD B+患者.
- 患者被随机分配,要么继续LABA/LAMA,要么在12个月内切换到单个吸入器的三重疗法 (流酸/umeclidinium/vilanterol).
- 主要结果是实现的临床控制水平 (CC),次要结果包括恶化率和FEV1.
主要成果:
- 第一个患者于2024年2月29日被录取.
- 研究结果预计将在2026年第一季度发布.
结论:
- 该ANTES B+研究是GOLD B+ COPD患者三重治疗的开创性研究.
- 这是第一个使用复合指数 (CC) 作为主要终点的COPD试验.
更多相关视频
相关概念视频
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
01:26COPD: Management Using Bronchodilators and Corticosteroids
197
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
197
01:20COPD: Pathogenesis and Clinical Features
263
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
263
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
01:28Pulmonary Tuberculosis V
177
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
177
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.7K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K